Cargando…

Progress in the Treatment of Migraine Attacks: From Traditional Approaches to Eptinezumab

Migraine is the second cause of disability and of lost years of healthy life worldwide. Migraine is characterized by recurrent headache attacks and accompanying disabling symptoms lasting 4–48 h. In episodic migraine, attacks occur in less than 15 days per month and in chronic migraine, in more than...

Descripción completa

Detalles Bibliográficos
Autores principales: Scuteri, Damiana, Bagetta, Giacinto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465143/
https://www.ncbi.nlm.nih.gov/pubmed/34577624
http://dx.doi.org/10.3390/ph14090924